Crossref
Evaluation of Gemcitabine–De Gramont Regimen In The Treatment Of Hepatocellular Carcinoma
Research in Oncology · 2006
DOI: 10.21608/resoncol.2006.357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Oncology, 2006. Verfasst von Tarek Hashem und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hashem, T., El-Aziz, K. A., Ahmed, T., Metwaly, H., Al-Sherbiny, M., El-Ghany, A. A., Tawfeek, E., El-Bary, N. A., & Ahmed, R. (2006). Evaluation of Gemcitabine–De Gramont Regimen In The Treatment Of Hepatocellular Carcinoma. Research in Oncology. https://doi.org/10.21608/resoncol.2006.357
Vancouver
Hashem T, El-Aziz KA, Ahmed T, Metwaly H, Al-Sherbiny M, El-Ghany AA, et al. Evaluation of Gemcitabine–De Gramont Regimen In The Treatment Of Hepatocellular Carcinoma. Research in Oncology. 2006. doi:10.21608/resoncol.2006.357
BibTeX
@article{Hashem2006,
author = {Hashem, Tarek and El-Aziz, Khaled Abd and Ahmed, Tounis and Metwaly, Hassan and Al-Sherbiny, Mohamed and El-Ghany, Ashraf Abd and Tawfeek, Eman and El-Bary, Naser Abd and Ahmed, Rehab},
title = {Evaluation of Gemcitabine–De Gramont Regimen In The Treatment Of Hepatocellular Carcinoma},
journal = {Research in Oncology},
year = {2006},
doi = {10.21608/resoncol.2006.357}
}
EUVIMED